SCHEMBL2365601

SCHEMBL2365601

COc1cc2c(cc1C(F)(F)F)CCN(C)CC2

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.61
MAOA P21397 2/20 0.61
SLC6A4 P31645 1/20 0.61
DRD1 P21728 3/20 0.53
DRD5 P21918 3/20 0.53
DRD4 P21917 2/20 0.53
HTR2A P28223 3/20 0.50
DRD2 P14416 2/20 0.48
DRD3 P35462 2/20 0.48
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
MAP4K1 Q92918 1/20 0.45
CHRNA7 P36544 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11169272 0.82 MAOA (0.84) MAOBMAOASLC6A4DRD1DRD5
SCHEMBL13928803 0.81 AR (0.52) MAOBMAOASLC6A4HTR2AHTR2C
SCHEMBL2201182 0.81 HTR2A (0.60) MAOBMAOASLC6A4DRD1DRD5
Hydrochloric Acid SCHEMBL11158000 0.81 MAOA (0.81) MAOBMAOASLC6A4DRD1DRD5
SCHEMBL25946942 0.78 MAOA (0.75) MAOBMAOASLC6A4DRD1DRD5
SCHEMBL19427959 0.77 HTR2C (0.46) HTR2AHTR2CHTR2B
SCHEMBL20756625 0.76 HTR2A (0.62) HTR2AHTR2CHTR2BLMNA
SCHEMBL30634713 0.76 MAOB (1.00) MAOBMAOASLC6A4DRD1DRD5
SCHEMBL12010114 0.76 MAOA (0.67) MAOBMAOASLC6A4DRD1DRD5
SCHEMBL5525085 0.76 MAOB (1.00) MAOBMAOASLC6A4DRD1DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2363394-A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders Arena Pharmaceuticals, Inc. (US) 2011-09-07 EP disclosed